Where Operational Leaders Come Together to Enable Science
The 9th Lab Asset & Facility Management Summit is the only event dedicated to the operational integration layer between lab operations, asset management, facilities, and EHS. Join 190+ pharma and biotech leaders to tackle real-world challenges through the new Discover → Develop → Action format, designed to maximize peer-to-peer learning and practical problem solving.
Experience the community-led LAFM Exchange, where attendees shape the conversations, and take part in the R&D Action Day, hands-on, playbook-driven workshops that deliver tangible frameworks you can immediately apply to build leaner, smarter, and more resilient research environments.
Unmissable Event Highlights
The New LAFM Exchange
No presentations, no sales pitches, just community-led discussions where attendees set the agenda and collaborate on solving the most pressing challenges facing lab and site operations.
The R&D Action Day
Hands-on, playbook-driven workshops focused on workflow optimization with Sanofi and Ensoma, operational resilience with Takeda and Solid Biosciences, and cross-functional alignment with Pfizer, Gilead, QurAlis, and Sanofi, equipping you with frameworks you can implement immediately.
Running the Lab & Running the Site
Two dedicated tracks, boiling it down to the absolute operational fundamentals, addressing the unique challenges of lab operations and facilities management, from asset visibility and lean workflows to maintenance maturity and infrastructure reliability within this new area constrained environment.
AI, Automation & Smarter Operations
Separate hype from reality by exploring where AI and automation truly create operational impact, improve asset performance, and reduce workload while maintaining compliance and control with Kardigan and Empress Therapeutics.
Building Leaner, More Resilient Research Environments
Discover practical strategies to do more with less through reliability-centred maintenance, risk-based decision making, predictive maintenance, workforce continuity, and stronger alignment across lab operations, facilities, procurement, and engineering.
Divide & Conquer
Track A: Running the Site
Building resilient infrastructure to keep research moving.
Designed for facilities, engineering, maintenance, and site leaders, the Running the Site track explores how to maintain reliability, strengthen operational ownership, and make smarter decisions in an era of constrained budgets and increasing complexity. Through the new Discover → Develop → Action format, attendees will move from expert insights to collaborative discussions and practical roundtables designed to turn ideas into implementation.
Featured topics include:
- Separating AI reality from hype to identify where automation actually reduces operational workload with Kardigan
- Applying reliability-centred maintenance principles to extend asset lifecycles with Alnylam Pharmaceuticals
- Aligning leadership priorities across site functions to reduce operational friction with Monimoi Therapeutics
- Standardizing governance models to enable faster decisions and clearer accountability with ACADIA Pharmaceuticals
- Prioritizing capital investments using risk-based frameworks with Takeda
- Preparing facilities teams for emergency, supply chain, and infrastructure disruptions
Track B: Running the Lab
Optimizing operations to deliver more time back to science.
Built for lab operations, asset management, and research support leaders, the Running the Lab track focuses on helping organizations do more with less, improve asset visibility, and create lean, efficient environments that maximize scientific productivity. Following the new Discover → Develop → Action journey, each session combines expert perspectives with interactive discussions and action-oriented roundtables to ensure tangible takeaways.
Featured topics include:
- Rebuilding asset visibility and inventory control to improve uptime with Regeneron
- Managing role creep in lean lab environments with EpiCypher
- Designing lean workflows to maintain throughput and data quality with Empress Therapeutics
- Reducing scientific delays by clarifying ownership between lab operations, facilities, and vendors with Novartis
- Converting asset criticality into failure-proof maintenance strategies with Gilead Sciences
Explore the Full Event Guide
Explore the Full Event Guide to See:
- The brand-new LAFM Exchange, where the community sets the agenda, ensuring discussions focus on the operational challenges that matter most to lab operations, facilities, and asset management leaders.
- Our new Discover → Develop → Action format, designed to move beyond presentations and create more meaningful conversations, peer benchmarking, and practical problem-solving opportunities.
- The R&D Operations Action Day, featuring hands-on, playbook-driven workshops that deliver tangible frameworks and implementation plans you can immediately apply within your own organization.
- Two focused content tracks, Running the Lab and Running the Site, bringing together operational leaders to share strategies for improving efficiency, resilience, and time back to science.
- 28+ real-world case studies and interactive sessions from leading pharma and biotech organizations, providing practical insights to help you build smarter, leaner, and more resilient research environments
Attending Companies Include
Explore the Agenda
Stop firefighting. Start futureproofing.
See how 30+ industry leaders are tackling AI adoption, asset visibility, maintenance strategy, and operational resilience to deliver more time back to science.
Partner With the Community That Enables Science
Put your solutions in front of the people who keep R&D running.
Connect with senior leaders across lab operations, facilities, engineering, and asset management from companies such as Takeda, Boehringer Ingelheim, Novartis, Regeneron, Pfizer, and more actively seeking smarter ways to optimize research environments.
Solve Challenges With People Who Get It
No sales pitches. Just real conversations.
From speed networking to the new LAFM Exchange, connect with 190+ pharma and biotech peers to benchmark strategies, share lessons learned, and leave with solutions you can act on.